Intersect ENT
XENT
$28.24
Share price
0.00%
Change (1 day)
17.72%
Change (1 year)
Categories
Revenue for Intersect ENT (XENT)
Revenue in 2021: $0.10 B
According to Intersect ENT's latest financial reports the company's current revenue (TTM) is $0.10 B. In 2021 the company made a revenue of $0.10 B an increase over the years 2020 revenue that were of $80.55 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Intersect ENT from 2012 to 2021
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2021 | $0.10 B | 32.52% |
| 2020 | $80.55 M | -26.19% |
| 2019 | $0.10 B | 0.62% |
| 2018 | $0.10 B | 12.64% |
| 2017 | $96.3 M | 22.35% |
| 2016 | $78.7 M | 27.79% |
| 2015 | $61.59 M | 59.62% |
| 2014 | $38.58 M | 115.2% |
| 2013 | $17.93 M | 205.83% |
| 2012 | $5.86 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Ocular Therapeutix OCUL | $58.44 M | -45.25% | 🇺🇸 USA |
 ICON plc ICLR | $8.12 B | 7,506.86% | 🇮🇪 Ireland |
 Anika Therapeutics ANIK | $0.16 B | 56.13% | 🇺🇸 USA |
 Haemonetics HAE | $1.27 B | 1,089.89% | 🇺🇸 USA |